Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures... see more

GREY:ISOLF - Post Discussion

Isodiol International Inc > ISOL will open $1.00 - $2.00
View:
Post by HiMyNameIs on Apr 28, 2021 8:32am

ISOL will open $1.00 - $2.00

Everyone should go on jusbrasil.com.br and search purodiol, isodiolex, and isoderm one at a time and order it by date. You can see how incredibly popular and demanded they are by autism/epilepsy patients in brasil. Countless court orders pretty much every day and week to make brasil gov pay to supply these 3 medicines to patients. This is 10x what i've found.
The fact that the government is paying for and supplying isodiol products for all these patients is huge! the proof is all there. Undeniable proof of demand by autism/epilepsy patients, Undeniable proof of efficacy, and undeniable proof of government acceptance and funding to supply them... it seems pretty much guaranteed that these drugs will become equivalent in legal and medicinal status as Epidiolex but for Brazil and will likely spread to rest of LATAM and the world. These 3 drugs are worth 1 billion dollars minimum.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities